Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage br - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage br

General Cancer News Latest Breast Cancer News from Moreover Technologies

Prev

Previous Post

Next Post

Next

07-01-2013, 11:47 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	Genentech's Perjeta regimen gets FDA Priority Review for HER2-positive early stage br Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application for the use of a Perjeta (pertuzumab) regimen before surgery (neoadjuvant treatment) in people with HER2-positive early stage breast cancer. More...

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 06:39 PM.

free webpage hit counter